Valuation: SWK Holdings Corporation

Market Cap 19Cr 17Cr 16Cr 14Cr 27Cr 1.83TCr 27Cr 182.83Cr 72Cr 915.36Cr 72Cr 71Cr 3.05TCr P/E 2024
14.7x
P/E 2025 -81.9x
Enterprise Value 18Cr 15Cr 14Cr 13Cr 25Cr 1.68TCr 25Cr 167.52Cr 66Cr 838.69Cr 66Cr 65Cr 2.79TCr EV / Sales 2024
8.06x
EV / Sales 2025 5.11x
Free-Float
96.8%
Yield 2024 *
-
Yield 2025 -
6 months-7.83%
Current year-7.56%
Current year 15.71
Extreme 15.71
17.63
1 year 13.91
Extreme 13.91
17.9
3 years 13.17
Extreme 13.17
20.49
5 years 13.17
Extreme 13.17
20.49
10 years 0
Extreme 0
20.49
Date Insider Type Main position Quantity % Market Cap.
16/06/25 Free

Director

3,858 0.0315%
16/06/25 Free

Director

3,858 0.0315%
16/06/25 Free

Chairman

3,858 0.0315%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%+7.14%-0.56% 19Cr
+0.34%+3.27%-27.87%+1,225.98% 3.41TCr
+0.56%-1.96%-18.18%+1,088.12% 1.73TCr
+0.48%-1.03%+2.70%+96.74% 1.45TCr
+1.33%-2.95%+25.78%+56.19% 1.29TCr
-0.60%-0.45%-30.26%+78.39% 1.22TCr
+1.52%-1.60%-4.66%+73.07% 999.29Cr
-2.73%-1.04%+53.78%+139.13% 829.97Cr
+2.11%-6.93%-19.56%+34.62% 803.26Cr
Average +0.38%-3.28%-1.24%+310.19% 1.31TCr
Weighted average by Cap. +0.47%-2.71%-8.67%+560.53%

Financials

2024 2025
Net sales 2.75Cr 2.39Cr 2.24Cr 2.05Cr 3.87Cr 262.4Cr 3.92Cr 26Cr 10Cr 131.1Cr 10Cr 10Cr 436.37Cr 3.76Cr 3.26Cr 3.05Cr 2.79Cr 5.27Cr 358.02Cr 5.34Cr 36Cr 14Cr 178.88Cr 14Cr 14Cr 595.38Cr
Net income 1.35Cr 1.17Cr 1.1Cr 1Cr 1.89Cr 128.48Cr 1.92Cr 13Cr 5.03Cr 64Cr 5.06Cr 4.95Cr 213.67Cr -25.33L -21.98L -20.58L -18.83L -35.55L -24Cr -36.01L -2.41Cr -94.5L -12Cr -95.1L -93.04L -40Cr
Net Debt 2.8Cr 2.43Cr 2.27Cr 2.08Cr 3.92Cr 266.25Cr 3.97Cr 27Cr 10Cr 133.03Cr 10Cr 10Cr 442.77Cr -1.61Cr -1.4Cr -1.31Cr -1.2Cr -2.26Cr -153.46Cr -2.29Cr -15Cr -6.01Cr -77Cr -6.05Cr -5.92Cr -255.2Cr
Logo SWK Holdings Corporation
SWK Holdings Corporation is a life science focused specialty finance company partnering with small- and mid-sized commercial-stage healthcare companies. The Company provides non-dilutive financing to fuel the development and commercialization of lifesaving and life-enhancing medical technologies and products. The Company's solutions include structured debt, traditional royalty monetization, synthetic royalty transactions, and asset purchases typically ranging in size from $5.0 million to $25.0 million.
Employees
9
  1. Stock Market
  2. Stocks
  3. SWKH Stock